Abstract
Dr. Javier Fidalgo-Lopez, Dr. Guy Fournet, and Dr. Benoît Joseph are not included in the author byline. The contributions of these authors are as follows: Design and synthesis of BJJF078. Please view the correct author byline, affiliations, and citation here: Navina L. Chrobok 1 , John G. J. M. Bol 1 , Cornelis A. Jongenelen 1 , John J. P. Brevé 1 , Said El Alaoui 2 , Javier Fidalgo-Lopez 2 , 3, Guy Fournet 3 , Benoît Joseph 3 , Micha M. M. Wilhelmus 1 , Benjamin Drukarch 1 , Anne-Marie van Dam 1 These authors contributed equally to this work. 1 Department of Anatomy and Neurosciences, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, The Netherlands, 2 Covalab, Villeurbanne, France, 3 Institut de Chimie et Biochimie Moléculaires et Supramoléculaires, Université Claude Bernard—Lyon 1, Villeurbanne, France Chrobok NL, Bol JGJM, Jongenelen CA, Brevé JJP, El Alaoui S, Fidalgo-Lopez J, et al. (2018) Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis. PLoS ONE 13(4): e0196433. https://doi.org/10.1371/journal.pone.0196433 There is an error in the fifth sentence of the Materials and methods section under the subheading “Inhibition of recombinant Transglutaminase activity”. The correct sentence is: The two lyophilized TG2 inhibitors (see Fig 1 for chemical structure) BJJF078 (3,4-Dimethoxy-N-(5-[4-(acryloylamino)piperidine-1-sulfonyl]-naphthalen-1-yl)-benzamide, see S1 Appendix, synthetized and provided by Covalab, Villeurbanne, France and Institut de Chimie et Biochimie Moléculaires et Supramoléculaires, Villeurbanne, France) and ERW1041E (2-[(3-Bromo-4,5-dihydro-isoxazol-5-ylmethyl)-carbamoyl]-pyrrolidine-1—carboxylic acid quinolin-3-ylmethyl ester, kindly provided by Prof C. Khosla, Stanford University, USA) [18, 22, 23] were dissolved in DMSO (stock solution: 54 mM) and stored at -80C. (Figure Presented).
Cite
CITATION STYLE
Chrobok, N. L., Bol, J. G. J. M., Jongenelen, C. A., Brevé, J. J. P., El Alaoui, S., Fidalgo-Lopez, J., … Van Dam, A. M. (2018, December 1). Correction: Characterization of transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis (PLoS One (2018) 13:4 (e0196433) DOI: 10.1371/journal.pone.0196433). PLoS ONE. Public Library of Science. https://doi.org/10.1371/journal.pone.0209522
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.